Fredrick Hausheer
Plus aucun poste en cours
Profil
Fredrick Herman Hausheer was the founder and had founded BioNumerik Pharmaceuticals, Inc. in 1992, where he held the title of Chairman & Chief Executive Officer until 2015.
He has held former positions as Global Chief Medical Officer & Senior VP at Shanghai Stock Exchange and Wuxi Apptec, Inc. from 2019 to 2020, and as Global Chief Medical Officer at Lepu Biopharma Co., Ltd.
from 2020 to 2022.
Mr. Hausheer has a doctorate degree from the University of Missouri in 1982, an undergraduate degree from Graceland University in 1977, and a graduate degree from the University of Illinois At Urbana–Champaign in 1979.
Anciens postes connus de Fredrick Hausheer
| Sociétés | Poste | Fin |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Directeur Technique/Scientifique/R&D | 31/03/2022 |
Wuxi Apptec, Inc.
 Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Directeur Technique/Scientifique/R&D | 01/10/2020 |
Shanghai Stock Exchange
 Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | Sales & Marketing | 01/10/2020 |
BioNumerik Pharmaceuticals, Inc.
 BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Directeur Général | 01/06/2015 |
Formation de Fredrick Hausheer
| Graceland University | Undergraduate Degree |
| University of Illinois At Urbana–Champaign | Graduate Degree |
| University of Missouri | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Wuxi Apptec, Inc.
Wuxi Apptec, Inc. Data Processing ServicesTechnology Services Wuxi Apptec, Inc. provides pharmaceutical and biotechnology services. Its services include discovery, lab testing division, small molecule pharmaceutical development and manufacturing international discovery service unit, WuXi biologics, chemistry, bioanalytical, clinical & regulatory, genome center, biological reagents and WuXi venture fund. The company was founded by Ge Li in December 2000 and is headquartered in St. Paul, MN. | Technology Services |
Shanghai Stock Exchange
Shanghai Stock Exchange Investment Banks/BrokersFinance Shanghai Stock Exchange provides marketplace and facilities for securities trading. Its services include formulating business rules, accepting and arranging listings, organizing and monitoring securities trading, regulating members & listed companies, managing, and disseminating market information. The company was founded on November 26, 1990 and is headquartered in Shangha, China | Finance |
BioNumerik Pharmaceuticals, Inc.
BioNumerik Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX. | Health Technology |